Tislelizumab plus low-dose nab-paclitaxel “demonstrated enduring efficacy while maintaining a manageable safety profile,” according to researchers.

The most common symptom is blood in the urine (hematuria), which may appear pink, red, or brown. Other signs include frequent ...

The American Cancer Society estimates that 83,000 new cases of bladder cancer will be diagnosed this year, with nearly 17,000 ...

Medically reviewed by Steffini Stalos, DO Bladder cancer occurs when cancerous cells form in the tissues of the bladder, the ...

BCG therapy is associated with a high frequency of side effects in NMIBC; however, when used in sequential combination with ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Bladder cancer is not the only cancer affected by the rule. Patients diagnosed with pancreatic, skin and thyroid cancers ...

Discover how a groundbreaking study links cholesterol-lowering therapy to reduced bladder cancer growth offering hope for ...

ImmunityBio will part with 10 employees this quarter. Last fall, it cut 31 employees. The moves come as the biotech works to ...

Incorporating multiparametric magnetic resonance imaging (mpMRI) for initial staging can reduce the time to correct tr ...